Merck and Moderna announce positive Phase 3 results for individualized neoantigen therapy in melanoma.

{
  "signal_id": "c4457d5b-0eeb-4378-91fd-97621c43d8de",
  "signal_type": "twitter-company-posts",
  "signal_subtype": "twitter_post",
  "detected_at": "2026-08-19T10:57:40+00:00",
  "company": {
    "name": "Merck",
    "domain": "merck.com"
  },
  "data": {
    "tags": [
      "Pharmaceuticals",
      "Medical Research",
      "Partnership",
      "Product Development"
    ],
    "urls": [
      "https://go.merck.com/~819"
    ],
    "summary": "Merck and Moderna announce positive Phase 3 results for individualized neoantigen therapy in melanoma.",
    "hashtags": [
      "melanoma"
    ],
    "is_reply": false,
    "language": "en",
    "mentions": [
      "@moderna_tx"
    ],
    "post_url": "https://x.com/Merck/status/2090030431534006549",
    "tweet_id": "2090030431534006549",
    "num_likes": 184,
    "num_views": 38871,
    "post_text": "In collaboration with @moderna_tx, we’re excited to share the first positive Phase 3 topline results for our investigational individualized neoantigen therapy (INT) in combination with our company’s immunotherapy in the adjuvant setting for certain patients with completely resected stage IIB-IV #melanoma: https://t.co/DgmBU78TF2",
    "num_quotes": 29,
    "initiatives": [
      {
        "topic": "collaboration with Moderna on individualized neoantigen therapy",
        "urgency": 0.8
      },
      {
        "topic": "Phase 3 clinical trial for melanoma treatment",
        "urgency": 0.9
      }
    ],
    "num_replies": 23,
    "num_reposts": 54,
    "posted_date": "Wed Aug 19 10:57:40 +0000 2026",
    "num_bookmarks": 17,
    "posting_source": "Twitter for iPhone",
    "company_twitter_url": "https://x.com/Merck",
    "company_twitter_handle": "Merck",
    "technologies_mentioned": [
      {
        "name": "Moderna",
        "status": "integrated"
      }
    ],
    "company_twitter_dm_open": false,
    "company_twitter_location": "Rahway, NJ",
    "company_twitter_verified": true,
    "company_twitter_followers": 217284,
    "company_twitter_following": 952,
    "company_twitter_total_tweets": 8884,
    "company_twitter_account_created": "Tue Apr 28 02:40:05 +0000 2009",
    "company_twitter_verification_type": "Business"
  }
}

curl https://signals.autobound.ai/v1/signals/c4457d5b-0eeb-4378-91fd-97621c43d8de \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"merck.com","limit":20}'